AHPAW

Avista Public Acquisition Corp. II Warrant (AHPAW)

About Avista Public Acquisition Corp. II Warrant (AHPAW)

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Details

Daily high
$0.34
Daily low
$0.34
Price at open
$0.34
52 Week High
$1.39
52 Week Low
$0.24
Market cap
--
Dividend yield
0.00%
Volume
0
Avg. volume
124,172
P/E ratio
--

Avista Public Acquisition Corp. II Warrant News

Details

Daily high
$0.34
Daily low
$0.34
Price at open
$0.34
52 Week High
$1.39
52 Week Low
$0.24
Market cap
--
Dividend yield
0.00%
Volume
0
Avg. volume
124,172
P/E ratio
--